DUBLIN AND CAMBRIDGE, Mass. – Medtronic has teamed up with IBM Watson Health to develop the Sugar.IQ smart diabetes assistant, an intelligent app designed to simplify and improve daily diabetes management. The app leverages artificial intelligence and analytic technologies from IBM Watson Health to continually analyze how an individual’s glucose level responds to their food intake, insulin dosages, daily routines, and other factors, including information provided by the app user, and reveal patterns that give actionable insight. The Sugar.IQ app is available to users of the Medtronic Guardian Connect continuous glucose monitoring system.
You are here: / / Medtronic, IBM launch Sugar.IQ smart diabetes app